A more scientific approach to the safety evaluation of chemicals

  • Dennis V. Parke
Chapter

Abstract

The most extensive use of experimental animals is undoubtedly in the safety evaluation of drugs, food additives, pesticides, and other chemicals. Safety evaluation of a single drug or other chemical to the stage at which it can be marketed may involve the use of as many as 1,000 animals. The number of chemicals which have to be evaluated for safety each year is in excess of 1,000, so that in the United Kingdom alone several million experimental animals are likely to be used for the purposes of safety evaluation of chemicals. The extent of the problem is shown in table 1. Programmes of safety evaluation of chemicals involve a wide range of studies, from the LD50 test to three generation reproduction and carcinogenicity studies (see table 2). A variety of different animal species, from rodents to primates, may be used in these studies as models for man, in an attempt to evaluate the potential toxicity for the human consumer, but despite the recognition of major differences in the toxicology of chemicals between animals and man, safety evaluation is still largely empirical.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahr, H. J., King, L. J., Nastainczyk, W. and Ullrich, V. (1980) The mechanism of chloroform and carbon monoxide formation from carbon tetrachloride by microsomal cytochrome P-450. Biochem. Pharmacol., 29,2855–2861.PubMedCrossRefGoogle Scholar
  2. Bachur, N. R., Gordon, S. L., Gee, M. V. and Kon, H. (1979) NADPH-cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc.Natl.Acad.Sci.,U.S.A., 76, 954–957.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Bishun, N. P., Mills, J., Williams, D. C. and Parke, D. V. (1975) A cytogenic study in women who had used oral contraceptives, and their progeny. Mutation Res., 33, 299–310.PubMedCrossRefGoogle Scholar
  4. Booth, J., Boyland, E. and Cooling, C. (1967) The respiration of human liver tissue. Biochem.Pharmac., 16, 721–724.CrossRefGoogle Scholar
  5. Brown, D. M., Langley, P. F., Smith, D. and Taylor D. C. (1974) Metabolism of chloroform I. The metabolism of 14C-chloroform by different species. Xenobiotica, 4, 151–163.CrossRefGoogle Scholar
  6. Burk, R. F. and Lane, J. M. (1979) Ethane production and liver necrosis in rats after administration of drugs and other chemicals. Toxicol.Appl.Pharmacol., 50,467–468.PubMedCrossRefGoogle Scholar
  7. Committee of Safety of Medicines (1979) Medicines Act Information Letter, No. 25, Department of Health and Social Security, London, page 2.Google Scholar
  8. Elder, J. B. Gangoli, P. C. and Gillespie, I. E. (1979) Cimetidine and gastric ulcer. Lancet, 1,1005–1006.PubMedCrossRefGoogle Scholar
  9. Frank, L. and Massaro, D. (1980) Oxygen toxicity. Am.J.Med., 69,117–126.PubMedCrossRefGoogle Scholar
  10. Fridovich, I. (1978) The biology of oxygen radicals. Science, 201, 875–880.PubMedCrossRefGoogle Scholar
  11. Gibson, G. G. and Ioannides, C. (1981) Safety Evaluation of Nitrosatable Drugs and Chemical, Taylor and Francis, London.Google Scholar
  12. Harris, C. C. (1976) The carcinogenicity of anti-cancer drugs: a hazard in man. Cancer, 37, 1014–1023.PubMedCrossRefGoogle Scholar
  13. Ioannides, C. Parkinson, C. and Parke, D. V. (1981) Activation of benzo(a)pyrene and 2-acetamidofluorene to mutagens by microsomal preparations from different animal species: role of cytochrome P-450 and P-448. Xenobiotica, 11, 701–708.PubMedCrossRefGoogle Scholar
  14. Iveson, P. Lindup, W. E. Parke, D. V. and Williams, R. T. (1971) The metabolism of carbenoxolone in the rat. Xenobiotica, 1, 70–95.CrossRefGoogle Scholar
  15. Jenssen, D. and Ramel, C. (1980) The micronucleus test as part of a short-term mutagenicity test program for the prediction of carcinogenicity evaluated by 143 agents tested. Mutation Res., 75, 191–202.PubMedCrossRefGoogle Scholar
  16. Joint Meeting of FAO and WHO on Pesticide Residues, Report 1980 (1981) FAO Plant Production and Protection Paper 26, FAO, Rome, pp.6–7 and 53–56.Google Scholar
  17. Kornbrust, D. J. and Mavis, R. D. (1980) Microsomal lipid peroxidation. I. Characterization of the role of iron and NADPH. Mol.Pharmacol., 17, 400–407.PubMedGoogle Scholar
  18. Pacifici, G. M., Boobis, A. R., Brodie, M. J., McManus, M. E. and Davis, D. S. (1981) Tissue and species difference in enzymes of epoxide metabolism. Xenobiotica, 11, 73–79.PubMedCrossRefGoogle Scholar
  19. Parke D. V. (1982a) The disposition and metabolism of environmental chemicals by mammalia, in The Handbook of Environmental Chemistry, vol.2/part B (ed. O. Hutzinger), Springer-Verlag, Heidelberg, pp.141–178.Google Scholar
  20. Parke, D. V. (1982b) Mechanisms of toxicity: A unifying hypothesis. Regulatory Toxicology and Pharmacology, in press.Google Scholar
  21. Tanayama, S. (1973) Metabolism of 6-chloro-5-cyclohexindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. III. Species differences in metabolism. Xenobiotica, 3, 671–680.PubMedCrossRefGoogle Scholar
  22. Walker, C. H. (1978) Species differences in microsomal monooxygenase activity and their relationship to biological halflives. Drug Metabolism Rev, 7,295–323.CrossRefGoogle Scholar
  23. Wendel, A., Feuerstein, S. and Konz, K. H. (1979) Acute paracetamol intoxication of starved mice leads to lipid peroxidation in vivo. Biochem.Pharmacol.,28,2051–2055.PubMedCrossRefGoogle Scholar

Copyright information

© The Contributors 1983

Authors and Affiliations

  • Dennis V. Parke
    • 1
  1. 1.Department of BiochemistryUniversity of SurreyGuildfordUK

Personalised recommendations